Strs Ohio Avalo Therapeutics, Inc. Transaction History

Strs Ohio

  • $24.7 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022
SELL
$3.0 - $10.45 $115,200 - $401,280
-38,400 Closed
0 $0
Q4 2021

Jan 24, 2022
SELL
$19.68 - $28.68 $507,744 - $739,944
-25,800 Reduced 40.19%
38,400 $65,000
Q3 2021

Oct 22, 2021
BUY
$26.16 - $40.68 $1.68 Million - $2.61 Million
64,200 New
64,200 $139,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $105M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email